Topical administration of somatostatin prevents retinal neurodegeneration in experimental diabetes.
about
Neuroprotection as a Therapeutic Target for Diabetic RetinopathyThe db/db mouse: a useful model for the study of diabetic retinal neurodegeneration.Chicken embryos as a potential new model for early onset type I diabetes.Octreotide Protects the Mouse Retina against Ischemic Reperfusion Injury through Regulation of Antioxidation and Activation of NF-κBThe Neuropilin-1 Inhibitor, ATWLPPR Peptide, Prevents Experimental Diabetes-Induced Retinal Injury by Preserving Vascular Integrity and Decreasing Oxidative Stress.Oxidative stress impact on growth hormone secretion in the eyeSomatostatin protects photoreceptor cells against high glucose-induced apoptosis.Somatostatin and diabetic retinopathy: current concepts and new therapeutic perspectives.Diabetic retinopathy is a neurodegenerative disorder.Therapeutic targeting of diabetic retinal neuropathy as a strategy in preventing diabetic retinopathy.Growth Factors in the Pathogenesis of Retinal Neurodegeneration in Diabetes MellitusCurrent treatment strategies and nanocarrier based approaches for the treatment and management of diabetic retinopathy.Diabetic retinopathy: new therapeutic perspectives based on pathogenic mechanisms.Occludin downregulation in high glucose is regulated by SSTR2 via the VEGF/NRP1/Akt signaling pathway in RF/6A cells.Resveratrol Ameliorates Retinal Ischemia/Reperfusion Injury in C57BL/6J Mice via Downregulation of Caspase-3.Ocular delivery of proteins and peptides: challenges and novel formulation approaches.Release kinetics of somatostatin from self-assembled nanostructured hydrogels.Functional changes in the neural retina occur in the absence of mitochondrial dysfunction in a rodent model of diabetic retinopathy.Topical administration of DPP-IV inhibitors prevents retinal neurodegeneration in experimental diabetes.Effects of the neuroprotective drugs somatostatin and brimonidine on retinal cell models of diabetic retinopathy.Early retinal pigment epithelium dysfunction is concomitant with hyperglycemia in mouse models of type 1 and type 2 diabetes.Anti-inflammatory and retinal protective effects of capsaicin on ischaemia-induced injuries through the release of endogenous somatostatin.Caspases in retinal ganglion cell death and axon regeneration.The effect of fenofibrate on early retinal nerve fiber layer loss in type 2 diabetic patients: a case-control study.Effect of fenofibrate on retinal neurodegeneration in an experimental model of type 2 diabetesEffects of Liposomal Formulation of Citicoline in Experimental Diabetes-Induced Retinal Neurodegeneration
P2860
Q26749178-0C60C066-958D-4EB5-A57C-F6A313517B29Q33623614-EF4ECF23-D211-4B1D-B22F-B57051FF994AQ34003307-7B644D5C-B690-4963-B6D4-9D67E2F1CC34Q35794145-57ADEA84-6510-4307-B7EF-FC1EE9D557DDQ35836955-25C78CA8-36DA-40C7-AB36-625C397D197EQ36077937-A8D97647-A868-4FA3-80B4-EE8E6985D064Q37548629-0A87CAB4-D29D-4AC9-87D3-A9660F25C989Q38195792-D03FBF0E-D26D-4B36-B3FE-1F3EA1C8BC7BQ38730604-B2B19556-7239-430F-AB39-2B007F84C330Q38873909-6AC33B6A-FCC3-4274-A59B-384B60CF2CE5Q38928508-7312CF4D-11F0-4AB3-9C1E-37D65B2B65D6Q39103248-74B80E11-D8B9-4FF6-AA40-D4E51B5115F2Q39208422-B32D4D5D-B4BA-4691-AF74-6F80617ED825Q41116544-E079C1A1-65EE-4F84-B0AE-78033FD327F9Q47687272-A5C0F568-E743-4B2B-AE14-A0AFC4C57BBEQ47729137-E611E2DB-CC96-4802-8E5C-E8DA20AA09C4Q47801727-90A60AD1-807D-4A1C-BBF0-9233E56184B6Q47809831-3E836575-9D2D-4716-80F1-A94BDAFB56C5Q47988627-5175B734-356E-4438-8C27-D78E6939DEC1Q48099809-0D99EFDA-65F8-4347-A75F-1CF8A6D82FD2Q48169124-BDCD2A43-C1F3-483B-803B-23C1219AD721Q48248995-C9A60B1A-FFAF-4232-98A5-C81D1943B97FQ52575858-03347C66-A1D8-4F89-BE3E-3D7F70FC0F4FQ52579979-88006CF2-BE28-4BCC-81DB-554FEDFAD271Q58461756-3B4E0BE2-D116-40B5-BFBD-E7F6A25F0C26Q58734085-AF9B1357-E5F0-4589-8085-B17FB31D8497
P2860
Topical administration of somatostatin prevents retinal neurodegeneration in experimental diabetes.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Topical administration of soma ...... tion in experimental diabetes.
@en
Topical administration of soma ...... tion in experimental diabetes.
@nl
type
label
Topical administration of soma ...... tion in experimental diabetes.
@en
Topical administration of soma ...... tion in experimental diabetes.
@nl
prefLabel
Topical administration of soma ...... tion in experimental diabetes.
@en
Topical administration of soma ...... tion in experimental diabetes.
@nl
P2093
P2860
P356
P1433
P1476
Topical administration of soma ...... ation in experimental diabetes
@en
P2093
Angela M Valverde
Berta Ponsati
Cristina Hernández
Jimena Fernández-Carneado
Josep Farrera-Sinfreu
Lidia Corraliza
Rafael Simó
P2860
P304
P356
10.2337/DB12-0926
P407
P577
2013-03-08T00:00:00Z